Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127382692 | 12738269 | 2 | F | 200601 | 20160919 | 20160913 | 20160928 | EXP | US-PFIZER INC-2016414710 | PFIZER | 61.00 | YR | F | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127382692 | 12738269 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 10 MG, 1X/DAY | N | 20702 | 10 | MG | QD | |||||||
| 127382692 | 12738269 | 2 | C | DAILY VITAMINS | 2 | 0 | |||||||||||||
| 127382692 | 12738269 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127382692 | 12738269 | 1 | Blood cholesterol increased |
| 127382692 | 12738269 | 3 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127382692 | 12738269 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127382692 | 12738269 | Arthropathy | |
| 127382692 | 12738269 | Muscle spasms |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |